References
- Brien A J., Simon T L. The effects of red blood cell infusion on 10-km race time. JAMA 1987; 257: 2761–5
- Buick F J., Gledhill N, Froese A B., Spriet L, Meyers E C. Effect of induced erythrocythemia on aerobic work capacity. J Appl Physiol 1980; 48: 636–42
- Ekblom B, Goldbard A N., Gullbring B. Response to exercise after blood loss and reinfusion. J Appl Physiol 1972; 33: 175–80
- Williams M H., Wesseldine S, Somma T, Schuster R. The effect of induced erythrocythemia upon 5-mile treadmill run time. Med Sci Sports Exercise 1981; 13: 169–75
- Berglund B, Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Int Med 1991; 229: 125–30
- Eschach J W., Egrie J C., Downing M R., Browne J K., Adamson J W. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a combined Phase I and II clinical trial. N Engl J Med 1987; 316: 73–8
- Mayer G, Thum J, Cada E M., Stummvoll H K., Graf H. Working capacity is increased following recombinant human erythropoietin therapy. Kidney Int 1988; 34: 525–8
- Adamson J W., Vapnek D. Recombinant erythropoietin to improve athletic performance. N Engl J Med 1991; 324: 698–9
- Ergie J C., Strickland T W., Lane J, et al. Characterization and biological effects of recombinant human erythropoietin. Immunobiology 1986; 172: 213–24
- Castle W B., Jandl J H. Blood viscosity and blood volume: opposing influences upon oxygen transport in polycythemia. Semin Hematol 1966; 3: 193–8